Valuation Laboratorio Farmaceutico Erfo S.p.A.

Stocks

Market Closed - Borsa Italiana 11:45:00 2026-08-13 EDT			5-day change	1st Jan Change
1.125 ^EUR	-0.44%		-1.75%	-23.47%

07-06	Laboratorio Erfo continues buyback, acquires 15,000 treasury shares	AN
06-29	Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares	AN

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025
Market Cap ¹	18.27	11.79	10.8	12.53
Change	-	-35.47%	-8.4%	16.03%
Enterprise Value (EV) ¹	17.38	11.41	10.81	12.83
Change	-	-34.34%	-5.31%	18.7%
P/E	25.5x	19.1x	30.8x	17x
PBR	2.33x	1.43x	1.44x	1.57x
PEG	-0.3x	-1.4x	-0.8x	0x
Capitalization / Revenue	3.87x	1.99x	1.79x	1.29x
EV / Revenue	3.68x	1.92x	1.79x	1.32x
EV / EBITDA	11.8x	8.02x	10.1x	7x
EV / EBIT	17.6x	13.6x	20.6x	12x
EV / FCF	-	-	-	-
FCF Yield	-	-	-	-
Dividend per Share ²	-	0.06	-	-
Rate of return	-	4.58%	-	-
EPS ²	0.0796	0.0686	0.0411	0.0865
Distribution rate	-	87.4%	-	-
Net sales ¹	4.719	5.932	6.032	9.732
EBITDA ¹	1.474	1.423	1.065	1.832
EBIT ¹	0.987	0.8367	0.5239	1.066
Net income ¹	0.7161	0.5903	0.3528	0.737
Net Debt ¹	-0.8895	-0.3784	0.005767	0.2954
Reference price ²	2.030	1.310	1.265	1.470
Nbr of stocks (in thousands)	9,000	9,000	8,537	8,524
Announcement Date	4/12/23	5/8/24	4/14/25	4/12/26

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LABORATORIO FARMACEUTICO ERFO S.P.A.	-	-	-	-	11.11M
ELI LILLY AND COMPANY	34.6x	12.64x	25.73x	0.57%	1,088B
JOHNSON & JOHNSON	29.02x	-	-	2.06%	629B
ABBVIE INC.	31.76x	7.4x	15.37x	2.76%	440B
ROCHE HOLDING AG	20.37x	4.83x	11.97x	2.73%	359B
NOVARTIS AG	21.72x	5.63x	14.03x	2.85%	291B
ASTRAZENECA PLC	20.24x	4.18x	11.87x	2.1%	245B
AMGEN INC.	26.11x	6.86x	12.2x	2.42%	225B
NOVO NORDISK A/S	13.56x	4.86x	10.12x	3.76%	204B
GILEAD SCIENCES, INC.	-42.19x	6.04x	34.06x	2.43%	168B
Average	17.24x	6.55x	16.92x	2.41%	364.92B
Weighted average by Cap.	24.66x	8.26x	18.73x	1.97%